Through
4/26
A new study finds that combining CAR T thereapy with an enzyme-inhibitor drug allows the engineered cells to battle through jumbled blood vessels and attack tumors.
The Presidential Professor of cancer biology leads a team that is working to understand how cancer grows uncontrolled in cells and discovering novel ways to stop it.
New research shows a statistically significant increased risk of testicular cancer among those reporting at least three exposures to X-ray, including a colon X-ray, and CT below the waist.
The discovery of a unifying mechanism could inform new therapeutic approaches to prevent normal cells from transforming into any type of tumor.
Abbreviated MRI shortens the screening time and requires only three sequences, while traditional ultrasound’s limitations don’t detect cancer as reliably for women with higher breast density.
An international team, co-led by the School of Dental Medicine’s George Hajishengallis, showed how immune “training” transforms certain immune cells to target tumors.
During the pandemic, a Penn-developed algorithm helped sustain end-of-life care discussions with patients with cancer.
A virtual conference on cancer and COVID-19 discussed how medical professionals adapt to a rapidly changing environment and enforce protocols to deliver care safely, while individuals are choosing to skip cancer screenings or delay treatments.
The assistant professor of systems pharmacology and translational therapeutics, who studied with Carl June as a postdoctoral fellow, combines his two research passions—gene therapy and investigating ‘little known’ biology—in the pursuit of new knowledge.
A Penn study uncovers new roles of chaperone-mediated autophagy in how stem cells repair or regenerate damaged organs.
A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.
FULL STORY →
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
A trial led by Susan Domchek of the Perelman School of Medicine could use a preventive vaccine to protect people with a BRCA gene mutation from cancer.
FULL STORY →
Penn Medicine researchers like Nobel laureate Drew Weissman are leading efforts to develop a vaccine that prevents cancer, with remarks from Susan Domchek of the Basser Center for BRCA and Robert H. Vonderheide of the Abramson Cancer Center.
FULL STORY →
Daiwei Zhang and Mingyao Li of the Perelman School of Medicine and colleagues have developed an AI tool called iStar that can automatically spot tumors and types of cancer that are difficult for clinicians to see or identify and can predict candidates for immunotherapy.
FULL STORY →
The Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: lack of transportation to critically important appointments. Robert Vonderheide and Carmen Guerra of the Perelman School of Medicine are quoted on the Ride Health initiative.
FULL STORY →